文献速递心力衰竭与心肌病

癌症治疗相关心肌炎:心脏肿瘤学中新发临床综合征的病例定义建议

Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology.
PubMed 文献 · Circulation · 2019-01-01

本文针对癌症免疫治疗(尤其是免疫检查点抑制剂)相关的免疫介导性心肌炎,指出临床试验中该事件罕见且缺乏统一定义,导致发生率与预后难以评估。作者提出一套操作性病例定义,以促进病例确认与报告,增进对该综合征发生率、结局和风险因素的理解。

要点

  • 免疫检查点抑制剂相关心肌炎可从轻微症状到致命事件,临床表现异质。
  • 现有临床试验中心肌炎为研究者报告且缺乏特异性病例定义,诊断复杂。
  • 建议采用统一操作性定义以改善病例确认和报告。

核心结论

  • 建立癌症治疗相关心肌炎的统一操作性定义有助于病例确认和报告,从而增进对发生率、结局和风险因素的理解。

研究设计与样本

  • 本文为针对癌症治疗相关心肌炎病例定义的建议性文章,基于对免疫检查点抑制剂相关心肌炎临床报告与临床试验现状的观察。

主要发现

  • 免疫检查点抑制剂相关心肌炎的病例报告范围从轻微体征和症状到致命事件。
  • 随机临床试验中心肌炎为罕见事件,由研究者报告且缺乏特异性病例定义。
  • 诊断复杂性和临床表现异质性使临床试验及其他数据集中高特异性确认心肌炎具有挑战性。

临床怎么用

  • 在癌症免疫治疗临床试验中应用统一的心肌炎操作性定义,以促进病例确认和报告。

局限性

  • 免疫检查点抑制剂相关心血管疾病的全谱仍需完全界定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recent developments in cancer therapeutics have improved outcomes but have also been associated with cardiovascular complications. Therapies harnessing the immune system have been associated with an immune-mediated myocardial injury described as myocarditis. Immune checkpoint inhibitors are one such therapy with an increasing number of case and cohort reports describing a clinical syndrome of immune checkpoint inhibitor–associated myocarditis. Although the full spectrum of immune checkpoint inhibitor–associated cardiovascular disease still needs to be fully defined, described cases of myocarditis range from syndromes with mild signs and symptoms to fatal events. These observations in the clinical setting stand in contrast to outcomes from randomized clinical trials in which myocarditis is a rare event that is investigator reported and lacking in a specific case definition. The complexities associated with diagnosis, as well as the heterogeneous clinical presentation of immune checkpoint inhibitor–associated myocarditis, have made ascertainment and identification of myocarditis with high specificity challenging in clinical trials and other data sets, limiting the ability to better understand the incidence, outcomes, and predictors of these rare events. Therefore, establishing a uniform definition of myocarditis for application in clinical trials of cancer immunotherapies will enable greater understanding of these events. We propose an operational definition of cancer therapy-associated myocarditis that may facilitate case ascertainment and report and therefore may enhance the understanding of the incidence, outcomes, and risk factors of this novel clinical syndrome.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Bonaca MP, Olenchock BA, Salem JE, et al. Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology. Circulation. 2019. PMID: 31390169

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。